The World Health Organization (WHO) has come out to assure it’s support to Nigeria, on the acquisition of vaccines to tackle the current Covid-19 pandemic.
This came after reports surfaced that Nigeria had been disqualified from the COVAX scheme, which is the WHO-led initiative for equitable global access to coronavirus vaccines.
Speaking at a press briefing in Abuja, the WHO Country Representative in Nigeria, Walter Kazadi Mulomboo informed the press that WHO remains committed in supporting all countries in acquiring the Covid-19 vaccines. “Of all the 88 million AstraZeneca vaccine doses allocated to African countries for the first phase, Nigeria has received by far the largest allocation, with 16 million doses,” he said.
Senior health officials in Nigeria had said that the country was hoping to provide vaccines for at least a fifth of its population, target the purchase of 40 million Covid-19 vaccine doses.
According to Faisal Shuaib, director-general of Nigeria’s National Primary Healthcare Development Agency (NPHDA), several factors are considered in allocating the quantity of vaccines including the mortality rates from Covid-19, the number of new cases, the trend in the number of cases, the population of countries and the availability of the appropriate cold chain equipment.